Daily Stock List
Cardium Therapeutics, Inc. (CXM)
FeedBlitz, Greenbackers, SmarTrend Newsletters, CRWEPicks, PennyOmega, and DrStockPick reported earlier on Cardium Therapeutics, Inc. (CXM) and we highlight the Company as "One to Watch" here at the QualityStocks Daily Newsletter.
Cardium Therapeutics, Inc. focuses on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses with the potential to address significant unmet medical needs that have definable pathways to commercialization, partnering, and other economic monetizations. The Company's current medical opportunities portfolio focuses on health sciences and regenerative medicine. It includes the Tissue Repair Company, Cardium Biologics, and the Company's in-house MedPodium® Health Sciences healthy lifestyle product platform. Listed on the NYSE Amex, Cardium Therapeutics has their headquarters in San Diego, California.
Cardium's lead commercial product is the Excellagen™ topical gel for wound care management. It has recently received FDA clearance for marketing and sale in the U.S. The Company's lead clinical development product candidate Generx® is a DNA-based angiogenic biologic intended for the treatment of patients with myocardial ischemia due to coronary artery disease. Cardium's MedPodium™ is a portfolio of premium, science-based, easy to use nutraceuticals, metabolics, and aesthetics designed to promote health and well-being. Cardium also continues to evaluate new technologies and business opportunities.
In July 2009, Cardium completed the sale of their InnerCool Therapies medical device business to Royal Philips Electronics. This represents the first asset monetization from the Company's biomedical investment portfolio. Cardium earlier received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market and sell their Excellagen™ professional-use, sterile, syringe-based wound care product for the management of diabetic foot ulcers, pressure ulcers, and other dermal wounds. Excellagen™ is a highly refined fibrillar flowable bovine collagen topical gel (2.6 percent) intended to support a favorable wound healing environment.
In January of this year, Cardium Therapeutics announced that they entered into their first international agreement for the commercialization of Excellagen™ in the South Korean market. Cardium entered into a marketing and distribution agreement with BL&H Co. Ltd., an established pharmaceutical company based in Korea. The agreement is for the commercialization of Excellagen Formulated Fibrillar Collagen Gel in the South Korean market under a transfer price arrangement. Additionally, in January the Company initiated the ASPIRE clinical study at leading medical centers in Russia for Cardium's Generx® cardiovascular product candidate. Last month, Cardium initiated the U.S. market introduction of the Excellagen™ product for diabetic foot ulcers and other dermal wounds.
Yesterday, Cardium Therapeutics announced that they are currently exhibiting their new FDA-cleared Excellagen® professional-use, syringe-based wound care product for the management of diabetic foot ulcers, pressure ulcers, and other dermal wounds at the 2012 Spring Symposium on Advanced Wound Care (SAWC) being held April 19 - 22, 2012 in Atlanta, Georgia.
We are tracking Cardium Therapeutics, Inc. (CXM) on our radar screens as "One to Watch" next week here at the QualityStocks Daily Newsletter.
Cardium Therapeutics, Inc. (CXM) closed Friday's trading session at $0.25, up 5.44%, on 715,103 volume with 493 trades. The average volume for the last 60 days is 569,381. The 52-week low/high is $0.13/$0.59.
Skinvisible Pharmaceuticals, Inc. (SKVI)
Stock Guru, Bold Stocks, and The Dean reported earlier on Skinvisible Pharmaceuticals, Inc. (SKVI) and we are highlighting the Company as "One to Watch" here at the QualityStocks Daily Newsletter.
Skinvisible Pharmaceuticals, Inc. is a pharmaceutical research and development company with a patented polymer delivery system called Invisicare®. The Company licenses their proprietary formulations made with Invisicare®. This patented polymer delivery system offers life-cycle management and unique enhancements for topically delivered products. Invisicare® holds active ingredients on the skin for extended periods of time resisting wash off and perspiration, as well as releases actives and reduces irritation. Skinvisible has their headquarters in Las Vegas, Nevada.
The Company receives a combination of research and development fees, upfront license fees, and ongoing royalties for the life of the Invisicare® patent. Skinvisible's value also lies in the Company's ability to generate new IP continually on topical products formulated with Invisicare®. In addition to licensing, Skinvisible engages in co-development. They assist pharmaceutical clients in the early development of the most optimal formulation, which they then take forward into clinical testing. They also engage in life cycle management. They provide cost-effective solutions to global pharmaceutical companies by reformulating their products coming off patent with a new Invisicare® patent and new product benefits.
In essence, Invisicare® is targeted drug delivery. Skinvisible's patented Invisicare® technology delivers drugs on, in, or through the skin with a controlled release. The Company can tailor Invisicare® to almost any type of molecule and the needs of their customers. Notably, Invisicare® extends a product's patent life and uses less active ingredient to achieve the desired therapeutic effect.
Invisicare® also helps retain skin moisture levels and it shields from environmental attack. Additionally it contains fewer additives. Its formulations do not contain alcohol, silicones, waxes, or other organic solvents. Skinvisible licenses their patented Invisicare® formulations to established developers and manufacturers of dermatology, cosmetic, skincare, medical, consumer goods, and surgical products, in over-the-counter and prescription formats.
The Company's Invisicare® pipeline includes topical products for acne, topical analgesics & first aid, anti-aging, anti-fungal, anti-inflammatory, and antimicrobial hand sanitizing lotions. The pipeline also includes topical products for dermatitis/moisturizers, skin cancer, warts, UVA/UVB sunscreens, as well as scar treatment, long-lasting fragrances, wound care, pre-surgical treatments, and preventative treatments.
Last week, Skinvisible announced that their licensee, Women's Choice Pharmaceuticals LLC, a specialty pharmaceutical company based in Gilbert, Arizona, has partnered with Advanced Medical Enterprises, LLC (AME, Inc.) to market ProCort® in Puerto Rico. ProCort® is a topical prescription treatment for hemorrhoids formulated with Skinvisible's patented polymer delivery system Invisicare® and a combination of hydrocortisone acetate and pramoxine hydrochloride.
We are highlighting Skinvisible Pharmaceuticals, Inc. (SKVI) as "One to Watch" next week here at the QualityStocks Daily Newsletter.
Skinvisible Pharmaceuticals, Inc. (SKVI) closed Friday's trading session at $0.05, down 3.64%, on 19,000 volume with 2 trades. The average volume for the last 60 days is 28,773. The 52-week low/high s $0.03/$0.08.
ERF Wireless, Inc. (ERFB)
Pumps and Dumps and FeedBlitz reported earlier on ERF Wireless, Inc. (ERFB) and we are highlighting the Company as "One to Watch" here at the QualityStocks Daily Newsletter.
Founded in 2004, ERF Wireless, Inc. is a leading provider of enterprise-class wireless broadband products and services. They specialize in providing wireless and broadband product and service solutions to banking and commercial clients, the oil and gas industry, and other commercial and residential customers on a regional, national, and international basis. The Company's strategic business plan has positioned ERF Wireless as the nation's leading provider of secure wireless networks for the regional banking industry and one of the largest Wireless Internet Service Providers (WISPs) in the United States. ERF Wireless has their headquarters in League City, Texas.
ERF Wireless is the parent company of Energy Broadband, Inc., ERF Enterprise Network Services, ERF Wireless Bundled Services, ERF Wireless Messaging Services, and ERF Network Operations. The Company's principals have been in the wireless broadband, network integration, triple play FTTH, IPTV, and content delivery business for over four decades. The Company is continuing to aggressively build and operate wireless broadband networks across the nation, using a combination of acquisitions, partnerships, and new construction.
The Company has their proprietary CryptoVue® Network Security Appliance. So far, a number of community bank networks built by ERF Wireless utilizing CryptoVue® have replaced expensive T1 telephone networks and now connect more than 100 banking locations across three states. Furthermore, ERF Wireless has expanded their base of products and services. This includes a triple play Voice, Video, and Internet offering to exclusive luxury resort communities delivered over a Fiber-to-the-Home (FTTH) network.
The Company's Enterprise Network Services Division provides banks and financial institutions with secure, next generation high-speed data and voice communications. This is via their BranchNet, US-BankNet, and WiNet solutions. The Bundled Wireless Services Division provides an array of voice, data, Internet, and video services across the nation under the ERF Wireless brand, and the localized branding of other ISP companies that have been acquired. The Network Operations Division provides the overall daily maintenance and 24/7 monitoring of all wireless broadband networks that ERF Wireless constructs, acquires, maintains, and administers, as well as third party networks requiring these same services.
The Company also has their Wireless Messaging Services Division. This Division manufactures and supplies high-power wireless infrastructure equipment. Their Energy Broadband Division provides a unique wireless broadband product and service offering to the major oilfield producers and service providers. The Company has used their extensive wireless network coverage in the oil and gas production regions of Texas, New Mexico, Oklahoma, and Louisiana. This is to provide wireless high-speed broadband communications to drilling and production operations.
Last week, ERF Wireless announced that they engaged a major construction contractor to build out two additional high-speed wireless broadband networks in two separate areas of the Permian Basin region of West Texas adjacent to existing ERF Wireless networks. Additionally, ERF Wireless is using their own construction crews to construct three new networks that are near the extensive terrestrial wireless network system already owned and operated by ERF Wireless in Texas, New Mexico, and Oklahoma.
We have ERF Wireless, Inc. (ERFB) locked on our radar screens as "One to Watch" next week here at the QualityStocks Daily Newsletter.
ERF Wireless, Inc. (ERFB) closed Friday's trading session at $2.25, down 4.26%, on 13,124 volume wth 44 trades. The average volume for the last 60 days is 9,829. The 52-week low/high is $0.25/$9.00.
CYIOS Corp. (CYIO)
Nebula Stocks reported recently on CYIOS Corp. (CYIO), LevelStock and StockRod did previously, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
CYIOS Corp. provides and implements innovative solutions to complex business problems. The Company does this in the areas of consulting, knowledge management, systems integration, application development, program integration, project management, and more. Their solutions integrate industry best practices with Government initiatives to help their customers meet their mission-critical goals. CYIOS lists on the OTC Bulletin Board. The Company has their corporate headquarters in Washington, DC. CYIOS operates two subsidiaries. These are CYIOS Corp. and CKO Inc.
CYIOS offers Business Consulting, Program & Project Management and Information Technology solutions. For Business Consulting, the Company provides strategic planning and analysis consulting services. They also offer studies and analyses in performance-based contracting, earned value management and human capital management adhering to Government policies and directives. This includes the President's Management Agenda.
CYIOS provides agencies with business process and productivity improvement via the evaluation, analysis and examination of current management, organizational and business systems and processes. The Company offers their experience in ways to adopt and succeed with best practices - notably Information Technology Infrastructure Library/Information Technology Service Management (ITIL/ITSM), as well as Lean Six Sigma.
Concerning Program & Project Management, CYIOS provides Government agencies with a unique and proven program management methodology for performance-based contract management and personnel and program oversight. They also provide an innovative project and knowledge management approach for Government agencies. As pertains to customer management/liaisons, the Company's Customer Liaison staffing solution offers an agency high quality personnel that represent a client's agency or department.
As relates to staff accountability, their CYIPRO solution allows management to prioritize tasks for staff so that the right tasks are completed at the right time. Additionally, staff and project accountability can undergo tracking within CYIPRO Timesheet and the Time Utilization reports. For Information Technology, CYIOS offers Application Development, Asset/Inventory Management, and Encryption/Smart Cards/PKI services, along with other services.
CYIOS Corp. (CYIO) closed Friday's trading session at $0.02, even with yesterday's close. The average volume for the last 60 days is 36,570. The 52-week low/high is $0.01/$0.19.
Adarna Energy Corp. (ADRN)
OTCPicks reported earlier on Adarna Energy Corp. (ADRN), The Penny Stock Bull did previously, and we highlight the Company, here at the QualityStocks Daily Newsletter.
Headquartered in Alpharetta, Georgia, Adarna Energy Corp. is a clean technology development company. They formerly went by the name EcoSystem Corp. They changed their name to Adarna Energy Corp. in July of 2011. They focus on developing innovations designed to resolve compelling ecological challenges while producing value added carbon neutral and negative products. The Company is working to develop new clean technologies that reduce and reuse carbon emissions. Their plan is to develop, license, and support technologies and projects that beneficially reuse waste carbon emissions in ways that reduce consumption of fossil fuels, increase use of sustainable raw materials, and decrease production of wastes and emissions.
Adarna Energy has licensed a technology portfolio from GS CleanTech Corp., a subsidiary of GreenShift Corp. The technology portfolio includes several feedstock and product conditioning technologies, lipid and alcohol production and refining technologies, and carbon dioxide recycling and refining technologies. Adarna Energy has no license rights involving any of GS CleanTech's corn oil technologies. They are initially focusing on developing applications of these technologies for use in the existing renewable fuels industry.
During 2010 and 2011, Adarna Energy conducted research involving patent-pending technologies designed to recycle waste carbon emissions into value-added products. The Company plans to conduct additional testing this year. Their license with GS CleanTech provides that Adarna Energy has to pay royalties to GS CleanTech equal to 10 percent of their pre-tax net income deriving from commercial use of licensed technology. Successful commercialization will require sequential progression from bench, to pilot and finally commercial-scale pilot testing.
Adarna Energy's Management does not anticipate the completion of bench and pilot testing and commencing commercial operations with the licensed technologies during 2012. However, as they reported in November 2011, completion of testing and development of a reasonable assessment of the economic feasibility of large scale implementation may be achieved within 36 months, depending upon the results of additional testing and the availability of capital for additional research and development activities.
Adarna Energy Corp. (ADRN) closed today's session at $0.0001, even with yesterday's close, on 500,000 volume. The average volume for the last 60 days is 18,680,374. The 52-week low/high is $0.0001/$0.51.
Integrated Freight Corp. (IFCR)
Penny Stock Rumble, Beacon Equity Research, Stock Preacher, Penny Stocks Finder, and StockHideout reported earlier on Integrated Freight Corp. (IFCR), and we highlight the Company, here at the QualityStocks Daily Newsletter.
Trading on the OTC Bulletin Board, Integrated Freight Corp. is a motor freight company. They provide long haul, regional, and local service to their clientele. The Company was formed for the purpose of acquiring and consolidating operating motor freight companies. Integrated Freight's mission is to build a safe, reliable, and high-quality national freight carrier and customized logistics service with a diverse customer base that is well positioned in growing profitable markets. Integrated Freight has their corporate headquarters in Sarasota, Florida.
The Company specializes in dry and refrigerated truckload services, operating mainly in well-established traffic lanes in the Upper Midwest, Pacific Northwest, Texas, California, and the Atlantic seaboard. Mr. Paul A. Henley, the Company's Founder, Director and Chief Executive Officer, incorporated Integrated Freight in Florida on May 13, 2008. The operating side of their existing business started in the fall of 2008 with the purchase of two well-established motor freight carriers. Integrated Freight completed their fourth acquisition in April of 2011.
Integrated Freight's subsidiary companies have historically operated in well-established geographic traffic lanes defined by their clientele's distribution patterns. Under their roll-up and integration strategy, the Company has the capability to leverage overlap within the most heavily traveled lanes (especially between points in the upper Midwest and Texas) to realize increased cost and productivity improvements and streamline brokered freight. In addition, they anticipate that the formation of a company wide in-house brokerage and logistics system will allow for added revenue capture as Integrated Freight progresses towards their goal of becoming one of the largest freight carriers in the United States.
This past January, Integrated Freight announced the successful completion of their refinancing and restructuring of equipment totaling $3.6 million, at their Cross Creek Trucking subsidiary. This included financing by Utica Leaseco of $2.6 million. Cross Creek Trucking is a Medford, Oregon-based motor carrier that specializes in transporting refrigerated organic fruit and vegetables.
Integrated Freight Corp. (IFCR) closed Friday's trading at $0.03, even with yesterday's close. The average volume for the last 60 days is 7,232. The 52-week low/high is $0.01/$0.35.
Canyon Copper Corp. (CNYC)
Bull Ventures reported recently on Canyon Copper Corp. (CNYC), StockGuru reported previously, and we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Canyon Copper Corp. is a resource company with two advanced mineral resource properties in the Western United States. Canyon Copper has their headquarters in Vancouver, British Columbia. The Company's shares list on the OTC Bulletin Board and on the TSX Venture Exchange (CNC.V). The Company's New York Canyon property is 30 miles (48 km) east of Hawthorne, Nevada. This property consists of 24 patented claims covering 420 acres (170 hectares) of which 18 are leased; and 1,293 unpatented mining claims covering approximately 25,860 acres (10,781 hectares). Therefore, this is for a total area of approximately 42 sq. miles.
For their Longshot Ridge target, Canyon Copper has obtained an indicated mineral resource estimate, at a cut-off grade of 0.2 percent copper, of 16,250,000 tons at an average grade of 0.43 percent Cu, and an inferred mineral resource estimate, at a cut-off grade of 0.2 percent copper, of 2,900,000 tons at an average grade of 0.31 percent Cu. The Company's objectives include an aggressive drill program to expand the current NI 43-101 Oxide Copper resource. They are also working to develop a database for an economic scoping study. Furthermore, they are establishing a project pipeline of other significant Copper deposits.
In December 2011, Canyon Copper advised that the new assay results for the 33 drill hole program carried out on Longshot Ridge in 2006 have been received and will be applied in a recalculation of the 2010 resource estimate, which mineralization was modeled using only those holes drilled in the years previous to the 2006 program. This past January, Canyon Copper completed an agreement to acquire the Moonlight Copper Porphyry Property. The Property is located on the northern end of the Walker Lane Porphyry Trend.
In March, Canyon Copper announced that Giroux Consultants have been engaged to incorporate the 2006 drill program results into the 2010 Longshot Ridge oxide resource estimate. In late 2012, Canyon plans to drill test oxide mineralization that was identified to the north and northeast of the Longshot Ridge deposit. Two other areas of oxide copper occur in the north central part of the claims - the Buffington Springs and the Powerline Showings. These have yet to undergo assessment, but have potential as additional sources of oxide copper.
Canyon Copper Corp. (CNYC) closed Friday's trading session at $0.12, up 0.84%, on 652 volume with 2 trades. The average volume for the last 60 days is 37,709. The 52-week low/high is $0.08/$0.41.
iSIGN Media Solutions, Inc. (ISD.V)
Vantage Wire, StocksJournal, AllPennyStocks, and Investinginstockmarket.net reported earlier on iSIGN Media Solutions, Inc. (ISD.V), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
iSIGN Media Solutions, Inc. is a North American leader in multiplatform advertising solutions. These solutions use Bluetooth, Mobile, Wi-Fi and Location-Aware technologies to deliver rich media, permission-based messages to engage consumers more deeply and cost-effectively. The resulting business intelligence and real time metrics, gathered through the Company's patent-pending advertising platform, deliver insights into emerging consumer behaviors.
The insights help advertisers measure their efforts and make better business decisions to increase Return on Investment (ROI) and customer loyalty. iSIGN has their corporate headquarters in Richmond Hill, Ontario. The Company has R&D and customer support operations in Vancouver, British Columbia and Tampa, Florida.
iSIGN is a leading provider of interactive mobile advertising solutions that serves advertisers, manufacturers, retailers and advertising agencies throughout North America. In addition, iSIGN has grown to become the largest owner/operator of in-store digital media in Canada with 5,600 digital signs in 1,400 locations. Partners include AOpen America, Inc. and IBM, with solution distribution by BlueStar, Inc.
iSIGN began in the spring of 2006 as a digital signage company offering location-based proximity marketing from their signs to handheld mobile devices. They evolved to iSIGN's interactive media solutions. These consist of IMS 2.0 - their proprietary, feature-rich, flexible and scalable hardware and software. Today's IMS 2.0 features dual porting for Linux or Windows and multi-lingual capabilities. It also has the Company's own 128-bit encryption software for added security, and more features.
iSIGN has completed a partnership with NewsAd Advertising Ltd. to promote and resell iSIGN's technology and solutions in Asia. They also have patent pending registration in Canada, the U.S. and internationally for their Interactive Marketing Solutions (IMS) technology.
This week, iSIGN and Carroll Advertising, Inc., an independently owned and operated advertising company located in Boston, Massachusetts, announced that they signed a non-binding Letter of Intent (LOI). Under the terms of the LOI, Carroll has agreed to an upfront payment of $250,000 US in licensing fees, in exchange for 230 Licenses for iSIGN's Smart Antenna (SA) and related Interactive Marketing Solutions (IMS) 3.1 software, for a period of three years. Additionally, Carroll will receive exclusive rights to the New England territory.
iSIGN Media Solutions, Inc. (ISD.V) closed Friday's trading session at $0.30, up 11.11%, on 99,500 volume. The 52-week low/high is $0.22/$0.75.
SilverSun Technologies, Inc. (SSNT)
The QualityStocks Daily Newsletter would like to spotlight SilverSun Technologies, Inc. (SSNT). Today, SilverSun Technologies, Inc. closed trading at $0.155, up 10.71%, on 18.000 volume with 4 trades. The stock’s average daily volume over the past 60 days is 13,476, and its 52-week low/high is $0.005/$0.36.
SilverSun Technologies, Inc. (SSNT), via wholly-owned subsidiary SWK Technologies, is a premier total solutions provider specializing in business software for manufacturers and distributors. Established in 1988, the company focuses on meeting the needs of small-sized and mid-sized businesses ("SMB" marketplace) with accounting and business management products, including SilverSun's own proprietary software. The company also offers its own cloud-based solutions and provides network services (network configuration, data backup, 24/7 remote monitoring, etc.) to its clients.
SilverSun distinguishes itself from traditional software resellers by offering a wide range of value-added services, consisting primarily of programming, training, technical support, and other consulting and professional services. The company also provides software customization, data migration, business consulting, and implementation assistance for complex design environments. Currently, the company has over 1,000 active customers.
In addition to driving organic growth, SilverSun's aggressive growth strategy includes acquiring firms in the extensive and expanding SMB marketplace to create substantial value for its shareholders, employees, and partners. SilverSun aims to leverage SWK Technologies as a platform to roll up and aggregate the best and brightest ERP resellers, as well as other software companies with proprietary products that serve the SMB marketplace. The company's most recent acquisition was in January 2012.
In 2011, SilverSun increased sales 40% over the previous year and strengthened its balance sheet through the elimination of all outstanding debt. With organic sales accelerating, significant debt reduction, and great depth of expertise and resources, SilverSun is well positioned to become a dominant player in the growing business software marketplace. Disclaimer
SilverSun Technologies, Inc. Blog
SilverSun Technologies, Inc. News:
SilverSun Technologies Announces Subsidiary SWK Technologies Closes on Another Major Sage ERP X3 Sale
SilverSun Technologies Closes Transaction Valued at $115,000
SilverSun Technologies Reports Record Revenues and Earnings for Full Year 2011
GlobalWise Investments (GWIV)
The QualityStocks Daily Newsletter would like to spotlight GlobalWise Investments, Inc. (GWIV). Today, GlobalWise Investments, Inc. closed trading at $1.67, off by 1.18%, on 18,366 volume with 10 trades. The stock’s average daily volume over the past 60 days is 6,009, and its 52-week low/high is $1.20/$1.87.
GlobalWise Investments, Inc. (GWIV), via wholly-owned subsidiary Intellinetics, Inc., is a leading-edge technology company focused on Enterprise Content Management (ECM) solutions for the digital age. The ECM industry continues to grow rapidly as a result of unrestricted proliferation of digital content within today's business environment. Leveraging its proprietary cloud-based computing software, GlobalWise is poised to capture a significant market share of this burgeoning industry.
GlobalWise's ECM service is delivered to customers via five unique delivery models which cover the spectrum of business needs: Cloud/Saas (Software as a Service), Hardware Vendor Integrated Service, Software Vendor Integrated Service, Premise (Client-Server), Hybrid (Premise & Cloud/Saas).This diversity gives advanced security & privacy features with an on-demand structure needed for large Tier 3 and Tier 4 businesses that are currently underserved by the market.
The Intellinetics platform defines a new industry benchmark and game-changing approach by combining advanced virtualization & automated content management with an open and service-oriented architecture using web services. The company provides strategies, tactics, and technologies used to manage paper and digital assets from capture to long-term archive, without the need for manual processes conducted by a full time employee.
GlobalWise's management boasts a combined total of over 60 years in ECM leadership and industry experience. The ECM industry is expected to exceed $5.1 billion by 2013 with Gartner predicting a compound annual growth rate of 9.5%. IBM Market Insights predicts adoption of cloud computing to grow by 26% CAGR between 2010 through 2013. Leveraging management and key department heads, Intellinetics has a strong foundation from which to capture significant market share within the lucrative $149 billion Business Software & Services industry. Disclaimer
GlobalWise Investments Company Blog
GlobalWise Investments News:
GlobalWise Provides Case Study on CareWorks
GlobalWise Announces Channel Sales Partnership With FormFast
GlobalWise Joins the Center for Digital Education to Expand K-12 Educational Services
TiVUS, Inc. (TIVU)
The QualityStocks Daily Newsletter would like to spotlight TiVUS, Inc. (TIVU). Today, TiVUS, Inc. closed trading at $0.0005, even for the day, on 25,017,488 volume with 29 trades. The stock’s average daily volume over the past 60 days is 33,446,354, and its 52-week low/high is $0.0001/$0.0265.
TiVUS, Inc. (TIVU) is a cutting edge provider of information, content distribution, media management and secure communications to the hospitality industry. The company's state of the art digital technology platform and Internet Protocol (IP) infrastructure presents hotels with a valuable opportunity to generate new revenue while enhancing guests' experiences by providing content that is more relevant to their unique interests.
The company's integrated platform stands far beyond the competition, offering unparalleled guest services such as messaging, folio review, express check outs, energy management and other personalized services while providing the traditional services of Free to Guest (FTG) programming, Video-On-Demand programming, a highly secured high speed internet service and many other interactive services such as gaming.
By combining TV and the web world through unparalleled IPTV/HDTV service, hotels are able to generate additional income through commercial spots, advertisements of local tourist services, hotel promotions and more. Features of the platform includes remote administration, support for more than twenty languages, easy installation and a comprehensive hotel services menu capable of providing detailed information about the hotel and upcoming activities, billing information, room service, guest messages and wake-up services.
The system's architecture consists of a Network Operating Center (NOC) and local hotel servers connected through a point-to-point broadband network. As each guest accesses the network, the resulting traffic generated undergoes analysis based on various criteria. This includes behavioral, geographical, seasonality, and more. Using this data, hotels are able to ensure advertisers maximum value for their advertising budget. Disclaimer
TiVUS, Inc. Company Blog
TiVUS, Inc. News:
TiVUS Names Steven D. Truckenmiller EVP
TiVUS Offers Free-to-Guest Hotel TV Digital Programming
TiVUS' Ad-Insertion Attracts Diverse Range of Advertisers
Consorteum Holdings, Inc. (CSRH)
The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.0035, even for the day, on 72,000 volume with 3 trades. The stock’s average daily volume over the past 60 days is 374,446, and its 52-week low/high is $0.001/$0.0205.
Consorteum Holdings, Inc. (CSRH) utilizes the most technically advanced global solutions available today. By working with a multitude of global technologies, Consorteum is able to create customized programs for maximum results. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.
Through its exclusive software license with Tarsin Inc., the company leverages a team of software developers that understands the complexities of delivering digital media content across mobile handsets. Tarsin is capable of providing clients with integration and support for over 700 mobile carriers globally on a seamless and secure platform to take advantage of the increasing demand for rich mobile content.
Consorteum's flagship CAPSA technology platform brings a universal solution to the problems of wagering and betting on mobile devices. Multiple different operating systems, user interfaces, and form factors have created enormous barriers to launching commercial initiatives. But with CAPSA, gaming operators can now cost-effectively monetize innovative mobile wagering products and services quickly and robustly.
In addition to its mobile initiatives, Consorteum is also actively engaged in the financial industry, providing MasterCard solutions as well as loyalty and reward programs. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer
Consorteum Holdings, Inc. Company Blog
Consorteum Holdings, Inc. News:
Consorteum Holdings wholly-owned subsidiary Tarsin, a Leader in Secure Mobile Platform Technology, Forges New Frontiers in Mobile Gaming
Consorteum Holdings Completes Acquisition of Tarsin Inc.
Consorteum Holdings, Inc. Announces Lead Spokesman for the First Nations MasterCard Program
Advanced Cell Technology, a biotech company focused on the field of regenerative medicine, today reported the successful completion of the dosing of the third patient in its phase I/II trial for dry age-related macular degeneration (AMD) using retinal pigment epithelial (RPE) cells from human embryonic stem cells (hESCs).
The company has already conducted the procedure in six other patients at UCLA, and said it anticipates adding more sites in the near future. Gary Rabin, chairman and CEO of ACT, also noted the prestige of individuals participating in the trials.
“The completion of enrollment of the first cohort of patients in our dry AMD clinical trial is a significant step forward in our RPE clinical program. The first six patients in the U.S. trials have all been treated at UCLA, and as we have recently announced, the trials should soon expand to additional sites,” Rabin stated in the press release. “As we have built our clinical team, we have been fortunate to have attracted the attention of some of the highest-caliber ophthalmologists and related institutions in the U.S. and Europe and recognize the huge value that their expertise provides us as we plan for the future of our therapeutic programs. With their guidance, we have also worked with the FDA to successfully expand the criteria of eligibility for patients to participate in our dry AMD trial.”
The procedures at UCLA were all conducted by the team led by Steven Schwartz, M.D., Ahmanson, professor of ophthalmology at the David Geffen School of Medicine at UCLA and retina division chief at UCLA’s Jules Stein Eye Institute.
Dr. Schwartz reports that there have been no complications with any of the procedures, nor have there been any safety issues.
ACT currently is conducting three clinical trials in the U.S. and Europe using hESC-derived RPE cells as treatment for various forms of macular degeneration.
“We are extremely pleased with the progress being made in all three of our clinical trials here in the U.S. and the UK,” stated Robert Lanza, M.D., ACT’s chief scientific officer. “The data we are reviewing seems to be pointing in the appropriate direction. … We still have many patients left to treat during the course of these trials, but our team remains hopeful that stem cell-derived RPE cells may someday provide a new therapeutic approach for the treatment of many forms of macular degeneration. We hear from patients who suffer from these diseases on nearly a daily basis, and appreciate the huge responsibility we have to them.”
Cardium Therapeutics is a health sciences and regenerative medicine company, whose business model is designed to avoid reliance on a single technology platform or product type, creating multiple opportunities for success. The company seeks to bridge the gap between promising new technologies and product opportunities that are ready for commercialization. They are focused on the acquisition and development of new and innovative bio-medical product opportunities and businesses, targeting significant unmet medical needs that have a definable pathway to commercialization, partnering, and other forms of monetization.
Cardium’s lead commercial product is Excellagen topical gel for wound care management. The company recently received FDA clearance for marketing and sale in the U.S., and they are currently exhibiting the product at the 2012 Spring Symposium on Advanced Wound Care (SAWC) in Atlanta, Georgia. Excellagen is designed to assist the healing of diabetic foot ulcers, pressure ulcers, and other dermal wounds. It’s a highly-refined collagen-based topical gel, having a unique high molecular weight bovine Type I collagen formulation with a number of advantages for doctors. Market research indicates that physicians seek easy-to-use products to reduce preparation time and facilitate product application. Excellagen comes in ready-to-use pre-filled syringes, requiring no thawing or mixing, and only a thin layer needs to be applied over the wound area. In addition, it calls for application at only one or two week intervals. Excellagen represents a combination of effectiveness and ease of use unmatched in the marketplace.
Cardium’s medical opportunities portfolio includes other promising candidates, and includes the Tissue Repair Company, Cardium Biologics, and the company’s in-house MedPodium® Health Sciences healthy lifestyle product platform. Their lead clinical development product candidate is Generx, a DNA-based angiogenic biologic that is intended for the treatment of patients with myocardial ischemia due to coronary artery disease. Cardium continues to actively evaluate new technologies and business opportunities.
For additional information, visit the company’s website at www.CardiumThx.com. For more information regarding Excellagen, visit www.Excellagen.com.
Today, PeopleString, a company on the bleeding edge of integrated social marketing, which has made a name for itself with the “Insta Portal” that virtualizes the net into custom homepages for users, who can then leverage social connections and normal internet activity to generate capital through the building of a personal financial network, signed a letter of intent (LOI) to acquire 51% of BiLo Media, Inc., whose revolutionary Myingo (site/card) framework will provide consumers massive fuel savings at some 20k brand name pumps, just in time for the busy summer travel season.
Additionally, 25-year veteran business growth management, finance, operations, and (private/public) capital formation giant, Scott Harkness, current CEO of BiLo, will move to the CEO slot at PLPE, bringing his extensive experiential knowledge to the helm of the company.
The LOI calls for purchase of 51% of BiLo in exchange for 10M shares of PLPE restricted common stock (subject to due customary due diligence and approval by both companies).
BiLo’s Fuel Savings MYINGO Member Card should make serious waves this summer, as a discount pre-paid gas card that works at some of the nation’s largest retailers, saving consumers on average as much as $0.12-18 cents/gallon, will be hungrily sought after by a summer market full of people tired of high fuel prices and looking to go on vacation.
BiLo intends to expand this program to include more national retailers and restaurants, integrating with PeopleString, offering it to their members, supercharging the current national advertising campaign for the PeopleString Social network and “Share it Up” social coupon platform. A BiLo engine/suspension driving a PeopleString social network chassis, this is the vehicle that you will see on America’s roads this summer, as the BiLo marketing team steps up to the plate and takes control of these extant PLPE operations.
President and CEO of PLPE, Darin Myman, was extremely excited to have Harkness take the reins of PLPE, confident that Scott and his team of industry experts will execute superbly on the task of making PeopleString a household name. The vast advertising, marketing, and e-commerce capabilities evident in the perfectly timed adding of BiLo’s gasoline discount program caught the neck of the rising fuel cost trend, brilliantly showcasing management’s grasp of market dynamics and the technical framework required to achieve success.
Something the two companies have in common is a firm grasp of integrated social media networking and how it pertains to engineering truly 21st century, symbiotic marketing, and product distribution webs.
Harkness emphasized this congruity, citing the dynamic, popular social platform for which PeopleString is known (implemented via an intuitive, no-fuss, no nonsense Insta Portal that captures the web for consumers in one easy homepage), and the broad national Merchant relationships BiLo Media has access to, as a perfect combination. All the right elements come together in this deal, with the most powerful aspects of social marketing, media, and commerce now fused into the machinery of PeopleString. A solution emerges in the underlying logistics that is unprecedented for the end user in terms of appeal; families can now obtain life essentials at unbeatable savings, all within a framework of simplified, reloadable offering, as well as easy redemption.
The ability of people to build social financial empires that benefit them in a compounding, cyclical manner, where they earn when others in their string earn, is something that tantalizes the imagination of consumers and tickles the pocket book. People already visit sites, use apps, play games, use social networks, and read contact emails online every day, the PeopleString Insta Portal captures and virtualizes the process, making it fun and easy to make money while doing things already done daily.
Rosetta Genomics announced today that it has received a grant from the European Patent Office for a patent claiming the use of miR-34a for the preparation of pharmaceuticals to treat p53-negative cancers. A core element of Rosetta Genomics’ microRNA technology in the development of p53-negative-related cancer therapeutics is covered in the issued claims. The patent is owned jointly with Yeda, a technology transfer company of the Weizmann Institute of Science in Rehovot, Israel.
The p53 protein, a sequence-specific transcription factor, functions as a major tumor suppressor in mammals. One of the most frequent genetic alterations in human cancer is the inactivation of the p53’s tumor-suppression function, and almost half of all human tumors carry p53 gene mutations within their cells. The new patent covers the invention disclosing the finding that miR-34a – a direct transcriptional target of p53 – has anti-proliferative and pro-apoptotic activities, which contribute to the tumor-suppressor effects of activated p53.
The overexpression of miR-34a promotes anti-proliferative effects and contributes to cell death, while inactivation of miR-34a decreases p53-mediated cell death. miR-34a is, therefore, a direct transcriptional target of p53 and may mediate some of this tumor suppressor’s biological effects. The perturbation of miR-34a expression may resultantly contribute to tumorigenesis.
Rosetta Genomics offers a series of microRNA-based diagnostic products called miRview that accurately diagnose various types of cancers. The company estimates that in the U.S. alone, more than 300,000 patients each year could benefit from some of the various miRview tests, and more than 1 million patients across the globe can benefit from miRview’s lung test alone.
Rosetta Genomics is a leading developer and provider of microRNA-based molecular diagnostics. The company’s integrative research platform, combining bioinformatics and cutting-edge laboratory processes, has led to the discovery of hundreds of biologically validated novel human microRNAs. Leveraging its strong patent position and proprietary platform technologies, the company is in the process of applying these technologies to the development and commercialization of a full range of microRNA-based diagnostic tools. Rosetta Genomics’ miRview product line is available commercially through the company’s Philadelphia-based, CAP-accredited, CLIA-certified lab.
Today's Top 3
Mina Mar Marketing
The QualityStocks Public Company Sponsor News